Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Riboflavin | 1 | 2020 | 5 | 0.710 |
Why?
|
| Amnion | 1 | 2020 | 4 | 0.710 |
Why?
|
| Blood Platelets | 4 | 2019 | 203 | 0.700 |
Why?
|
| Ultraviolet Rays | 1 | 2020 | 41 | 0.690 |
Why?
|
| Stem Cell Transplantation | 1 | 2017 | 17 | 0.570 |
Why?
|
| Swine | 1 | 2017 | 220 | 0.530 |
Why?
|
| Platelet Adhesiveness | 2 | 2009 | 6 | 0.400 |
Why?
|
| Endothelium, Vascular | 5 | 2000 | 305 | 0.390 |
Why?
|
| Collagen | 2 | 2019 | 147 | 0.340 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2009 | 23 | 0.330 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2009 | 16 | 0.320 |
Why?
|
| Membrane Glycoproteins | 5 | 2002 | 143 | 0.320 |
Why?
|
| Flow Cytometry | 1 | 2009 | 282 | 0.300 |
Why?
|
| Stem Cells | 2 | 2020 | 113 | 0.300 |
Why?
|
| Cells, Cultured | 7 | 2017 | 970 | 0.280 |
Why?
|
| Fibronectins | 1 | 2006 | 28 | 0.270 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2006 | 15 | 0.270 |
Why?
|
| Calcium | 2 | 2000 | 231 | 0.260 |
Why?
|
| P-Selectin | 6 | 2002 | 30 | 0.250 |
Why?
|
| Nanotubes, Carbon | 3 | 2013 | 49 | 0.240 |
Why?
|
| Hemodynamics | 3 | 2019 | 220 | 0.230 |
Why?
|
| Neutrophils | 4 | 2001 | 177 | 0.230 |
Why?
|
| Cell Adhesion | 4 | 2001 | 133 | 0.200 |
Why?
|
| Models, Cardiovascular | 2 | 2019 | 46 | 0.190 |
Why?
|
| Blood Flow Velocity | 2 | 2009 | 63 | 0.180 |
Why?
|
| Signal Transduction | 4 | 2019 | 1344 | 0.180 |
Why?
|
| Cross-Linking Reagents | 1 | 2020 | 42 | 0.180 |
Why?
|
| Stress, Mechanical | 6 | 2002 | 102 | 0.170 |
Why?
|
| Vascular Remodeling | 1 | 2019 | 13 | 0.160 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2019 | 60 | 0.160 |
Why?
|
| Stress, Physiological | 1 | 2019 | 90 | 0.150 |
Why?
|
| Regional Blood Flow | 1 | 2019 | 159 | 0.150 |
Why?
|
| Intracellular Fluid | 2 | 2000 | 12 | 0.150 |
Why?
|
| Sus scrofa | 1 | 2017 | 12 | 0.140 |
Why?
|
| Adult Stem Cells | 1 | 2017 | 10 | 0.140 |
Why?
|
| Regenerative Medicine | 1 | 2017 | 17 | 0.140 |
Why?
|
| Immunophenotyping | 1 | 2017 | 58 | 0.140 |
Why?
|
| Adipocytes | 1 | 2017 | 53 | 0.140 |
Why?
|
| Models, Animal | 1 | 2017 | 129 | 0.140 |
Why?
|
| Humans | 15 | 2020 | 26827 | 0.130 |
Why?
|
| Adipose Tissue | 1 | 2017 | 179 | 0.130 |
Why?
|
| L-Selectin | 3 | 2000 | 11 | 0.120 |
Why?
|
| Cell Differentiation | 1 | 2017 | 395 | 0.120 |
Why?
|
| Engineering | 1 | 2013 | 9 | 0.110 |
Why?
|
| Mathematics | 1 | 2013 | 42 | 0.110 |
Why?
|
| Science | 1 | 2013 | 17 | 0.110 |
Why?
|
| Professional Competence | 1 | 2013 | 36 | 0.110 |
Why?
|
| Salts | 1 | 2013 | 12 | 0.110 |
Why?
|
| Lipid Bilayers | 1 | 2013 | 15 | 0.110 |
Why?
|
| Platelet Activation | 2 | 2006 | 54 | 0.110 |
Why?
|
| In Vitro Techniques | 2 | 2006 | 239 | 0.110 |
Why?
|
| Phospholipids | 1 | 2013 | 73 | 0.110 |
Why?
|
| Teaching | 1 | 2013 | 76 | 0.110 |
Why?
|
| Proto-Oncogenes | 1 | 1992 | 15 | 0.110 |
Why?
|
| Endothelium | 1 | 1992 | 28 | 0.100 |
Why?
|
| Multigene Family | 1 | 1992 | 50 | 0.100 |
Why?
|
| Animals | 9 | 2017 | 9958 | 0.100 |
Why?
|
| Adenosine Triphosphate | 1 | 1992 | 115 | 0.100 |
Why?
|
| Aorta | 1 | 1992 | 123 | 0.100 |
Why?
|
| Cell Movement | 3 | 2002 | 353 | 0.090 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 1990 | 4 | 0.090 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2008 | 73 | 0.090 |
Why?
|
| Arachidonic Acids | 1 | 1989 | 3 | 0.090 |
Why?
|
| Shear Strength | 1 | 2009 | 15 | 0.080 |
Why?
|
| Computer-Aided Design | 1 | 2009 | 14 | 0.080 |
Why?
|
| Equipment Failure Analysis | 1 | 2009 | 36 | 0.080 |
Why?
|
| Bioreactors | 1 | 2009 | 35 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 1992 | 627 | 0.080 |
Why?
|
| Equipment Design | 1 | 2009 | 211 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2006 | 129 | 0.080 |
Why?
|
| Cell Culture Techniques | 1 | 2009 | 115 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 508 | 0.070 |
Why?
|
| Recombinant Proteins | 2 | 2006 | 408 | 0.070 |
Why?
|
| Biomedical Engineering | 1 | 2006 | 7 | 0.070 |
Why?
|
| Histamine | 2 | 2000 | 9 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 747 | 0.070 |
Why?
|
| Glucosamine | 1 | 2006 | 6 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 2 | 2006 | 316 | 0.070 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2006 | 24 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 283 | 0.060 |
Why?
|
| K562 Cells | 2 | 2002 | 20 | 0.060 |
Why?
|
| Binding Sites | 1 | 2006 | 338 | 0.060 |
Why?
|
| Models, Molecular | 1 | 2006 | 441 | 0.060 |
Why?
|
| Glycoproteins | 2 | 2002 | 118 | 0.060 |
Why?
|
| Mucins | 2 | 2002 | 22 | 0.060 |
Why?
|
| HL-60 Cells | 2 | 2000 | 22 | 0.050 |
Why?
|
| Thrombin | 2 | 2000 | 68 | 0.050 |
Why?
|
| Second Messenger Systems | 2 | 1992 | 13 | 0.050 |
Why?
|
| Kinetics | 4 | 2001 | 538 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2002 | 245 | 0.050 |
Why?
|
| Water | 2 | 2013 | 131 | 0.040 |
Why?
|
| Calcimycin | 1 | 2000 | 11 | 0.040 |
Why?
|
| Peptides | 1 | 2002 | 280 | 0.040 |
Why?
|
| Tyrosine | 1 | 1999 | 90 | 0.040 |
Why?
|
| Cell Communication | 1 | 2000 | 66 | 0.040 |
Why?
|
| Smad2 Protein | 1 | 2019 | 16 | 0.040 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2019 | 20 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2019 | 43 | 0.040 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2019 | 50 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2019 | 64 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2019 | 110 | 0.040 |
Why?
|
| CHO Cells | 4 | 2001 | 96 | 0.040 |
Why?
|
| Cricetinae | 4 | 2001 | 129 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2019 | 221 | 0.040 |
Why?
|
| Ligands | 3 | 2002 | 168 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2019 | 324 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 1999 | 674 | 0.030 |
Why?
|
| E-Selectin | 1 | 1995 | 27 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 1999 | 1036 | 0.030 |
Why?
|
| Cell Membrane | 1 | 1995 | 235 | 0.030 |
Why?
|
| Technology Transfer | 1 | 2013 | 3 | 0.030 |
Why?
|
| Interinstitutional Relations | 1 | 2013 | 11 | 0.030 |
Why?
|
| Mentors | 1 | 2013 | 31 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2013 | 35 | 0.030 |
Why?
|
| Program Development | 1 | 2013 | 74 | 0.030 |
Why?
|
| Faculty | 1 | 2013 | 61 | 0.030 |
Why?
|
| Schools | 1 | 2013 | 69 | 0.030 |
Why?
|
| Self Efficacy | 1 | 2013 | 72 | 0.030 |
Why?
|
| Universities | 1 | 2013 | 115 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2013 | 162 | 0.030 |
Why?
|
| Genes, jun | 1 | 1992 | 3 | 0.030 |
Why?
|
| Leucine Zippers | 1 | 1992 | 7 | 0.030 |
Why?
|
| Genes, fos | 1 | 1992 | 13 | 0.030 |
Why?
|
| Fura-2 | 1 | 1992 | 10 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1992 | 43 | 0.030 |
Why?
|
| Rheology | 1 | 1992 | 21 | 0.030 |
Why?
|
| Diffusion | 1 | 1992 | 37 | 0.030 |
Why?
|
| Liposomes | 1 | 2013 | 142 | 0.030 |
Why?
|
| Drug Carriers | 1 | 2013 | 109 | 0.030 |
Why?
|
| Platelet Activating Factor | 1 | 1991 | 7 | 0.020 |
Why?
|
| Base Sequence | 1 | 1992 | 573 | 0.020 |
Why?
|
| Cattle | 1 | 1992 | 383 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 1990 | 32 | 0.020 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1989 | 14 | 0.020 |
Why?
|
| Carbon Radioisotopes | 1 | 1989 | 19 | 0.020 |
Why?
|
| Prostaglandins | 1 | 1989 | 12 | 0.020 |
Why?
|
| Culture Techniques | 1 | 1989 | 12 | 0.020 |
Why?
|
| Arachidonic Acid | 1 | 1989 | 18 | 0.020 |
Why?
|
| Biological Transport | 1 | 1989 | 109 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2008 | 21 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2008 | 44 | 0.020 |
Why?
|
| Adsorption | 1 | 2008 | 31 | 0.020 |
Why?
|
| Nanotubes | 1 | 2008 | 15 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2008 | 66 | 0.020 |
Why?
|
| Solubility | 1 | 2008 | 73 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2008 | 83 | 0.020 |
Why?
|
| Mice | 2 | 2008 | 4406 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2008 | 90 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2008 | 152 | 0.020 |
Why?
|
| BALB 3T3 Cells | 1 | 2006 | 5 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2006 | 43 | 0.020 |
Why?
|
| Surface Properties | 1 | 2006 | 132 | 0.020 |
Why?
|
| Materials Testing | 1 | 2006 | 86 | 0.020 |
Why?
|
| Rats | 1 | 2008 | 1545 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2008 | 273 | 0.010 |
Why?
|
| Tissue Engineering | 1 | 2006 | 152 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 6812 | 0.010 |
Why?
|
| Microspheres | 1 | 2002 | 47 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 310 | 0.010 |
Why?
|
| Biophysics | 1 | 2001 | 14 | 0.010 |
Why?
|
| Biophysical Phenomena | 1 | 2001 | 9 | 0.010 |
Why?
|
| Adult | 1 | 2013 | 7380 | 0.010 |
Why?
|
| Dimerization | 1 | 2001 | 75 | 0.010 |
Why?
|
| Transfection | 1 | 2001 | 312 | 0.010 |
Why?
|
| Models, Biological | 1 | 2002 | 446 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 1999 | 23 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1999 | 130 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1999 | 58 | 0.010 |
Why?
|
| Male | 1 | 2013 | 12867 | 0.010 |
Why?
|
| Gene Expression | 1 | 1999 | 406 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1999 | 276 | 0.010 |
Why?
|
| Female | 1 | 2013 | 14455 | 0.010 |
Why?
|
| Tensile Strength | 1 | 1995 | 32 | 0.010 |
Why?
|
| Polysaccharides | 1 | 1995 | 60 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1995 | 228 | 0.010 |
Why?
|
| Mutation | 1 | 1995 | 819 | 0.010 |
Why?
|
| Tritium | 1 | 1991 | 17 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 1991 | 25 | 0.010 |
Why?
|
| Acetates | 1 | 1991 | 44 | 0.010 |
Why?
|